Although the exact mechanisms responsible for this effect are unclear, we can postulate that chronic treatment with α5IA could alleviate cognitive deficits at least partly through the normalization of Sod1 expression in the hippocampus. The gene discussed is SOD1; the disease is Cognitive impairment.